VERNISHIA HILL GRAHAM: Open Payments
NPI 1679864870 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,464 in 85 payments from 30 companies in 2025. Trend: 2023 $1,926 · 2024 $1,758 · 2025 $1,464
Food & beverage: $1,464
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $161 |
| ABBVIE INC. | 12 | $147 |
| Otsuka America Pharmaceutical, Inc. | 7 | $138 |
| Axsome Therapeutics, Inc. | 6 | $108 |
| Lilly USA, LLC | 6 | $107 |
| Lundbeck LLC | 5 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $101 |
| Novo Nordisk Inc | 4 | $79 |
| Sumitomo Pharma America, Inc. | 4 | $61 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
Products named: REXULTI, Kerendia, VRAYLAR, FARXIGA, UBRELVY, GEMTESA, Auvelity, KISUNLA.
Industry payments across AL — which companies pay providers there.
